Clinical Trial Update: Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sorafenib as a monotherapy for inoperable or recurrent germ cell carcinoma refractory to chemotherapy. The condition is testicular canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Testicular Cancer

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Fondation Wygrajmy Zdrowie | Conditions: Testicular Cancer | Phase 2 | Status: UNKNOWN